IRONWOOD PHARMACEUTICALS INC

IRWD · Nasdaq · SIC 2834: Pharmaceutical Preparations
198
SEC Filings

Business Summary

PART I Our Company We are a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. We are focused on the development and commercialization of innovative product opportunities in areas of significant unmet need, leveraging our demonstrated expertise and capabilities in GI and rare diseases. LINZESS (linaclotide), our commercial product, is the first product approved by the United States Food and Drug Administ...

Next Earnings

Q2 FY2026 — expected 2026-09-06

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionIRWDdiscussed_in_filing Cybersecurity
topic_mentionIRWDdiscussed_in_filing Trusted Computing
topic_mentionIRWDdiscussed_in_filing Blockchain & Crypto
topic_mentionIRWDdiscussed_in_filing Supply Chain
topic_mentionIRWDdiscussed_in_filing Regulation
topic_mentionIRWDdiscussed_in_filing Healthcare & Bio
topic_mentionIRWDdiscussed_in_filing Sovereign & Government
topic_mentionIRWDdiscussed_in_filing Cybersecurity
topic_mentionIRWDdiscussed_in_filing Trusted Computing
topic_mentionIRWDdiscussed_in_filing Blockchain & Crypto
topic_mentionIRWDdiscussed_in_filing Supply Chain
topic_mentionIRWDdiscussed_in_filing Regulation
topic_mentionIRWDdiscussed_in_filing Healthcare & Bio
topic_mentionIRWDdiscussed_in_filing Sovereign & Government
topic_mentionIRWDdiscussed_in_filing Cybersecurity
topic_mentionIRWDdiscussed_in_filing Trusted Computing
topic_mentionIRWDdiscussed_in_filing Blockchain & Crypto
topic_mentionIRWDdiscussed_in_filing Supply Chain
topic_mentionIRWDdiscussed_in_filing Regulation
topic_mentionIRWDdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001104659-26-020489EDGAR86K words
2025-03-312024-12-310001558370-25-004072EDGAR
2024-02-162023-12-310001558370-24-001275EDGAR
2023-02-162022-12-310001558370-23-001462EDGAR
2022-02-182021-12-310001558370-22-001368EDGAR
2021-02-172020-12-310001558370-21-001136EDGAR
2020-02-132019-12-310001558370-20-000779EDGAR
2019-02-252018-12-310001558370-19-001005EDGAR
2018-02-222017-12-310001558370-18-000927EDGAR
2017-02-222016-12-310001558370-17-000793EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001104659-25-108795EDGAR28K words
2025-08-112025-06-300001558370-25-011050EDGAR
2025-05-122025-03-310001558370-25-007406EDGAR
2024-11-072024-09-300001558370-24-014909EDGAR
2024-08-082024-06-300001558370-24-011590EDGAR
2024-05-092024-03-310001558370-24-007640EDGAR
2023-11-092023-09-300001558370-23-018589EDGAR
2023-08-092023-06-300001558370-23-014242EDGAR
2023-05-042023-03-310001558370-23-008092EDGAR
2022-11-032022-09-300001558370-22-016235EDGAR
2022-08-042022-06-300001558370-22-012191EDGAR
2022-05-052022-03-310001558370-22-007359EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-110001104659-26-026123EDGAR1K words
2026-02-250001104659-26-019405EDGAR
2026-01-020001104659-26-000057EDGAR
2025-12-230001104659-25-123974EDGAR
2025-11-260001104659-25-116217EDGAR
2025-11-100001104659-25-108806EDGAR
2025-10-100001104659-25-098523EDGAR
2025-09-030001104659-25-087008EDGAR
2025-08-070001104659-25-074972EDGAR
2025-07-100001104659-25-066986EDGAR

198 total filings indexed. 166 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001446847
TickerIRWD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9b90293870a791d0fdaad8c74c54cece60b867c7a42cff24db7251cc810dbce3
parent: 4ba2de248059d4e2e2834ecadfeda126f35cb126dc827620dc06311b9f5e8430
content hash: e724df673e26e0ec9df1c5bd767bf50495743e3f7bce6f1ea2a84e6bf8a33ce6
signed: 2026-04-13T04:45:45.332Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf